Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Laser photocoagulation plus anti-VEGF versus anti-VEGF alone for diabetic macular edema
NL-OMON39983Active, not recruiting
- Sponsor
- Het Oogziekenhuis Rotterdam
- Start
- Jan 2014
- Countries
- 1
01
Overview
Randomised, open-label trial in diabetic macular edema (DME) (2 arms), sponsored by Het Oogziekenhuis Rotterdam. Primary endpoint: Proportion of failures to treatment. Started Jan 2014; status: active, not recruiting.
02
Conditions
diabetic macular edema (DME)
Beyond the preview
Go deeper on NL-OMON39983.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON39983.